Innate Pharma S.a Stock Forecast

Sell candidate since Jul 09, 2026

The Innate Pharma S.a. stock price fell by -0.139% on the last day (Monday, 13th Jul 2026) from $1.79 to $1.79. During the last trading day the stock fluctuated 5.75% from a day low at $1.74 to a day high of $1.84. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks. Volume has increased on the last day by 192 shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 12 thousand shares were bought and sold for approximately $21.44 thousand.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 19.00% during the next 3 months and, with a 90% probability hold a price between $1.88 and $2.96 at the end of this 3-month period.

IPHA Signals & Forecast

There are few to no technical positive signals at the moment. The Innate Pharma S.a. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $1.83 and $1.80. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, May 18, 2026, and so far it has fallen -20.44%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Innate Pharma S.a. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Innate Pharma S.a. stock

Innate Pharma S.a. finds support from accumulated volume at $1.76 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $0.100 (5.75%) between high and low. For the last week, the stock has had daily average volatility of 4.24%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (IPHA) For The Upcoming Trading Day Of Tuesday 14th

For the upcoming trading day on Tuesday, 14th we expect Innate Pharma S.a. to open at $1.79, and during the day (based on 14 day Average True Range), to move between $1.74 and $1.84, which gives a possible trading interval of +/-$0.105 (+/-6.03%) up or down from last closing price. If Innate Pharma S.a. takes out the full calculated possible swing range there will be an estimated 6.03% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.76 (1.68%) than the resistance at $2.02 (12.85%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Innate Pharma S.a. stock A Buy?

The Innate Pharma S.a. stock holds several negative signals and despite the positive trend, we believe Innate Pharma S.a. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -4.680 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 14, 2026 - $1.79 ( 0%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk